Toggle navigation
Home
Search
Services
Blog
Contact
About
4-Oxoretinol - Potential New Cancer Therapeutic Drug
Lane, Michelle A.
Weill Medical College of Cornell University, New York, NY, United States
Search 7 grants from Michelle Lane
Search grants from Weill Medical College of Cornell University
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Polarized Light Laparascopy of Occult Cancer Metastases
Chromium and Hedgehog signaling
Regulation of von Willebrand Factor - platelet binding by Force and Interdomain I
Nurse Practitioner & Nurse Midwifery Program
Holding and Maintenance of HIV AIDS Infected Rabbits
Recently added grants:
Developing computational algorithms for histopathological image analysis
Experimental and modeling investigations into microcircuit, cellular and subcellular determinants of hippocampal ensemble recruitment to contextual representations
Biased PAR1 Agonism in Sickle Cell Disease
Mechanisms of action contributing to decrease spasticity and improve motor recovery with repeated transcutaneous stimulation after spinal cord injury
The Effect of Tumor Microenvironment on Metastasis
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
1F32CA075722-01A1
Application #
2638266
Study Section
Special Emphasis Panel (ZRG2-SSS-1 (01))
Program Officer
Lohrey, Nancy
Project Start
1999-01-22
Project End
Budget Start
1998-08-10
Budget End
1999-08-09
Support Year
1
Fiscal Year
1998
Total Cost
Indirect Cost
Institution
Name
Weill Medical College of Cornell University
Department
Pharmacology
Type
Schools of Medicine
DUNS #
201373169
City
New York
State
NY
Country
United States
Zip Code
10065
Related projects
NIH 2000
F32 CA
4-Oxoretinol - Potential New Cancer Therapeutic Drug
Lane, Michelle A. / Weill Medical College of Cornell University
$40,013
NIH 1999
F32 CA
4-Oxoretinol - Potential New Cancer Therapeutic Drug
Lane, Michelle A. / Weill Medical College of Cornell University
NIH 1998
F32 CA
4-Oxoretinol - Potential New Cancer Therapeutic Drug
Lane, Michelle A. / Weill Medical College of Cornell University
Publications
Lane, Michelle A; Xu, Juliana; Wilen, Elana W et al.
(2008)
LIF removal increases CRABPI and CRABPII transcripts in embryonic stem cells cultured in retinol or 4-oxoretinol.
Mol Cell Endocrinol 280:63-74
Comments
Be the first to comment on Michelle Lane's grant